# OnCo record paper-aall1231-bortezomib-t-all-teachey-jco-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aall1231-bortezomib-t-all-teachey-jco-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aall1231-bortezomib-t-all-teachey-jco-2022" ;
  schema:name "AALL1231: bortezomib in newly diagnosed T-cell acute lymphoblastic leukaemia and lymphoma, with cranial radiotherapy removed"@en ;
  schema:description "In children with T-cell leukaemia or lymphoma, adding bortezomib to chemotherapy did not significantly improve survival for the whole group but did for those with lymphoma, and the intensified chemotherapy let more than nine in ten avoid radiotherapy to the brain without more relapses."@en ;
  schema:url <https://onco.cc/key-papers/paper-aall1231-bortezomib-t-all-teachey-jco-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.21.02678>, <https://pubmed.ncbi.nlm.nih.gov/35271306/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.21.02678> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Teachey DT, Devidas M, Wood BL, et al." ;
  onco:cancers <https://onco.cc/cancers/all-paediatric-high-risk/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:drugs <https://onco.cc/drugs/bortezomib/> ;
  onco:trials <https://onco.cc/trials/aall1231/> ;
  onco:journals <https://onco.cc/journals/jco/> .